Pharmacogenomics is the study of how genes affect a person's response to drugs. It can be used to help develop effective, safe medications and doses that will be tailored to a person's genetic makeup. We are continually expanding our tests within pharmacogenomics.
DPYD testing for 5 flourouracil chemotherapy toxicity
Genetic testing for the common DPYD genetic variants is recommended in some cancer patients.
Amynoglycoside exposure risk to hearing
Amynoglycosides, like some other medications, cause a debilitating side effect known as ototoxicity - the permanent loss of hearing or balance.